Ruthenium complexes as photosensitizers: New possibilities in photodynamic therapy

Ruthenium: Properties, Production and Applications

Volumn , Issue , 2011, Pages 249-268

  Swavey, Shawn ^a  

^a UNIVERSITY OF DAYTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHARGE TRANSFER; METAL COMPLEXES; PHOTOSENSITIZERS; RUTHENIUM COMPOUNDS; TERBIUM COMPOUNDS; TRANSITION METALS;

ANTICANCER DRUG; MACULAR DEGENERATION; METAL TO LIGAND CHARGE TRANSFERS; PHOTODYNAMIC EFFECT; PHOTODYNAMIC THERAPY (PDT); PHOTOPHYSICAL PROPERTIES; RUTHENIUM COMPLEXES; TREATMENT MODALITY;

PHOTODYNAMIC THERAPY;

EID: 84925619147     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (52)

1. Macdonald, IJ; Dougherty, TJ. Basic principles of photodynamic therapy; J. Porph. Phthal., 2000, 5, 105-129.
2. Neurath, RA; Strick, N; Cebinath, AK. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120, J. Mol. Recog., 1995, 8, 345-357.
3. Vzorov, AN; Dixon, DW; Trommel, JS; Marzilli, LG; Compans, RW. Inactivation of human immunodeficiency virus type 1 by porphyrins, Antimicrobial Agents and Chemotherapy, 2002, 46, 3917-3925.
4. Moan, J. Porphyrin photosensitization and phototherapy, Photochem. Photobiol., 1986, 43, 681-690.
5. Georgakoudi, I; Foster, TH. Effects of the subcellular redistribution of two nile blue derivatives on photodynamic oxygen consumption, Photochem. Photobiol., 1998, 68, 115-122.
6. Ravanant, JL; Douki, T; Cadet, J. Direct and indirect effects of UV radiation on DNA and its components, J. Photochem. Photobiol. B., 2001, 63, 88-102.
7. Belvedere, A; Bosca, F; Catalfo, A; Cuquerella, MC; de Guidi, G; Miranda, MA. Type II guanine oxidation photoinduced by the antibacterial fluoroquinolone rufloxacin in isolated DNA and in 2′-deoxyguanosine, Chem. Res. Toxicol., 2002, 15, 1142-1149.
8. Tronconi, M; Colombo, A; De Cesare, M; Marchesini, R; Woodburn, KW; Reiss, JA; Phillips, DR; Zunino, F. Biodistribution of haematoporphyrin analogues in a lung carcinoma model, Cancer Lett., 1995, 88, 41-58.
9. Pandey, RK. Recent advances in photodynamic therapy, J. Porph. Phthalocyan., 2000, 4, 368-373.
10. Allison, RR; Mota, HC; Sibata, CH. Clinical PD/PDT in North America: An historical review, Photodiag. Photodyn. Therapy, 2004, 1, 263-277.
11. Wei, WH; Wang, Z; Mizuno, T; Cortez, C; Fu, L; Sirisawad, M; Naumovski, L; Magda, D; Sessler, JL. New polyethyleneglycol-functionalized texaphyrins: synthesis and in vitro biological studies, Dalt. Trans., 2006, 1934-1942.
12. Chen. X; Drain, CM. Photodynamic therapy using carbohydrate conjugated porphyrins, Drug Design Reviews, 2004, 1, 215-234.
13. Dougherty, TJ; Gomer, CJ; Henderson, B.W; Jori, G; Kessel, D; Korbelik, M; Moan, J; Peng, Q; Photodynamic therapy, J. Nat. Canc. Inst., 1998, 90, 889-905.
14. Brewer, KJ. Tridentate-bridged polyazine complexes of ruthenium(II) and osmium(II) and their applications to the development of photochemical molecular devices, Comm. Inorg. Chem., 1999, 21, 201-224.
15. Hartshorn, RM; Barton, JM. Novel dipyridophenazine complexes of ruthenium(II):exploring luminescent reporters of DNA, J. Am. Chem. Soc., 1992, 114, 3919-3925.
16. Zeglis, BM; Pierre, VC; Barton, JK. Metallo-intercalators and metallo-insertors, Chem. Commun., 2007, 4565-4579.
17. Wagenknecht, HA; Stemp, EDA; Barton, JK. Evidence of electron transfer from peptides to DNA: oxidation of DNA-bound tryptophan using the flash-quench technique, J. Am. Chem. Soc., 2000, 122, 1-7.
18. Erkkila, KE; Odom, DT; Barton, JK. Recognition and reaction of metallointercalators with DNA, Chem. Rev., 1999, 99, 2777-2795.
19. Arkin, MR; Stemp, EDA; Holmlin, RE; Barton, JK; Hormann, A; Olson, EJC; Barbara, PF. Rates of DNA-mediated electron transfer between metallointercalators, Science, 1996, 273, 475-479.
20. Kelly, SO; Barton, JK. Radical migration through the DNA helix: chemistry at a distance, Metal Ions in Biological Systems V. 36, A. Sigel and H. Sigel, Marcel Dekker, NY. 1999, 211-249.
21. Dekker, C; Ratner, MA. Electronic properties of DNA, Physics World, 2001, 29-33.
22. Allardyce, CS; Dyson, PJ. Ruthenium in medicine: current clinical uses and future prospects, Platinum Metals Rev., 2001, 45, 62-69.
23. Fleisher, MB; Waterman, KC; Turro, NJ; Barton, JK. Light-induced cleavage of DNA by metal complexes, Inorg. Chem., 1986, 25, 3549-3551.
24. Pyle, AM; Rehmann, JP; Meshoyrer, R; Kumar, CV; Turro, NJ; Barton, JK. J. Am. Chem. Soc., 1989, 111, 3051-3058.
25. Lecomte, JP; Kirsch-De Mesmaeker, A; Orellana, G. Photophysics of polyazaaromatic ruthenium(II) complexes interacting with DNA, J. Phys. Chem., 1994, 98, 5382-5388.
26. Hergueta-Bravo, A; Jimenez-Hernandez, ME; Montero, F; Oliveros, E; Orellana, G. Singlet oxygen-mediated DNA photocleavage with Ru(II) polpyridyl complexes, J. Phys. Chem. B., 2002, 106, 4010-4017.
27. Zhou, QX; Yang, F; Lei, WH; Chen, JR; Li, C; Hou, YJ; Ai, XC; Zhang, JP; Wang, XS; Zhang, BW. Ruthenium(II) terpyridyl complexes exhibiting DNA photocleavage:the role of the substituent on monodentate ligand, J. Phys. Chem. B., 2009, 113, 11521-11526.
28. Zhou, QX; Lei, WH; Li, C; Hou, YJ; Wang, XS; Zhang, BW. DNA photocleavage in anaerobic conditions by a Ru(II) polypyridyl complex with long wavelength MLCT absorption, New. J. Chem., 2010, 34, 137-140.
29. Jain, A; Slebodnick, C; Winkel, BSJ; Brewer, KJ. Enhanced DNA photocleavage properties of Ru(II) terpyridine complexes upon incorporation of methylphenyl substituted terpyridine and/or the polyazine bridging ligand dpp (2,3-bis(2- pyridyl)pyrazine), J. Inorg. Biochem., 2008, 102, 1854-1861.
30. 2+, Inorg. Chem., 2004, 43, 7260-7262.
31. II bimetallic complexes with DNA, Inorg. Chem., 1997, 36, 4534-4538.
32. Milkevitch, M; Shirley, BW; Brewer, KJ. Mixed-metal polymetallic platinum complexes designed to interact with DNA, Inorg. Chim. Acta, 1997, 264, 249-256.
33. Fang, Z; Swavey, S; Holder, A; Winkel, B; Brewer, KJ. DNA binding of mixed-metal supramolecular Ru, Pt complexes, Inorg. Chem. Commun., 2002, 5, 1078-1081.
34. Williams, RL; Toft, NH; Winkel, B; Brewer, KJ. Synthesis, characterization, and DNA binding properties of a series of Ru, Pt mixed-metal complexes, Inorg. Chem., 2003, 42, 4394-4400.
35. Jain, A; Wang, J; Mashack, ER; Winkel, BSJ; Brewer, KJ. Multifunctional DNA interactions of Ru-Pt mixed metal supramolecular complexes with substituted terpyridine ligands, Inorg. Chem., 2009, 48, 9077-9084.
36. Prussin, AJ; Zhao, SL; Jain, A; Winkel, BSJ; Brewer, KJ. DNA interaction studies of tridentate bridged Ru(II)-Pt(II) mixed-metal supramolecules, J. Inorg. Biochem., 2009, 103, 427-431.
37. Holder, AA; Swavey, S; Brewer, KJ. Design aspects for the development of mixedmetal supramolecular complexes capable of visible light induced photocleavage of DNA, Inorg. Chem., 2004, 43, 303-308.
38. 5+, Inorg. Chem., 2002, 41, 6196-6198.
39. Swavey, S; Brewer, KJ. Synthesis and study of Ru, Rh, Ru triads: modulation of orbital energies in a supramolecular architecture, Inorg. Chem., 2002, 41, 4044-4050.
40. Onuki, J; Ribas, AV; Medeiros, MHG; Araki, K; Toma, HE; Catalani, LH; Di Mascio, P. Supramolecular cationic teteraruthenated porphyrin induces single-strand breaks and 8-oxo-7,8-dihydro-2′-deoxyguanosine formation in DNA in the presence of light, Photochem. Photobiol., 1995, 63, 272-277.
41. Araki, K; Silva, CA; Toma, HE; Catalani, LH; Medeiros, MHG; Di Mascio, P. Zinc tetraruthenated porphyrin binding and photoinduced oxidation of calf-thymus DNA, J. Inorg. Biochem., 2000, 78, 269-273.
42. Schmitt, F; Govindaswamy, P; Suss-Fink, G; Ang, WH; Dyson, PJ. Juillerat-Jeanneret, L; Therrien, B; Ruthenium poprhyrin compounds for photodynamic therapy of cancer, J. Med. Chem., 2008, 51, 1811-1816.
43. +, Trans. Metal Chem., 2003, 28, 852-857.
44. Davia, K; King, D; Hong, Y; Swavey, S. A porphyrin-ruthenium photosensitizer as a potential photodynamic therapy agent, Inorg. Chem. Commun., 2008, 11, 584-586.
45. Yang, SI; Seth, J; Strachan, JP; Gentemann, S; Kim, D; Holten, D; Lindsey, JS; Bocian, DF. Ground and excited state electronic properties of halogenated tetraarylporphyrins. Tuning the building blocks for porphyrin-based photonic devices, J. Porph. Phthaloc., 1999, 3, 117-147.
46. Samaroo, D; Vinodu, M; Chen, X; Drain, CM. meso-tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line, J. Comb. Chem., 2007, 9, 998-1011.
47. + groups, Inorg. Chim. Acta, 2006, 359, 2256-2262.
48. Rani-Beeram, S; Meyer, K; McCrate, A; Hong, Y; Nielsen, M; Swavey, S. A fluorinated ruthenium porphyrin as a potential photodynamic therapy agent: synthesis, characterization, DNA binding, and melanoma cell studies, Inorg. Chem., 2008, 47, 11278-11283.
49. Cunningham, M; McCrate, A; Nielsen, M; Swavey, S. Highly efficient visible-light induced photocleavage of DNA by a ruthenium-substituted fluorinated porphyrin, Eur. J. Inorg. Chem., 2009, 1521-1525.
50. McCrate, A; Carlone, M; Nielsen, M; Swavey, S. Anaerobic photocleavage of supercoiled DNA by a ruthenium(II) substituted fluorinated porphyrin, Inorg. Chem. Commun., 2010, 13, 537-539.
51. Craver, E; McCrate, A; Nielsen, M; Swavey, S. Tris-ruthenium(II)/copper(II) multimetallic porphyrin: synthesis, characterization, DNA binding and supercoiled DNA photocleavage studies, Inorg. Chim. Acta, 2010, 363, 453-456.
52. Gianferrara, T; Bratsos, I; iengo, E; Milani, B; Ostric, A; Spagnul, C; Zangrando, E; Alessio, E. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity, Dalt. Trans., 2009, 10742-10756.